237 related articles for article (PubMed ID: 27916409)
1. Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
van Rijn PA; Daus FJ; Maris-Veldhuis MA; Feenstra F; van Gennip RGP
Vaccine; 2017 Jan; 35(2):231-237. PubMed ID: 27916409
[TBL] [Abstract][Full Text] [Related]
2. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
[TBL] [Abstract][Full Text] [Related]
3. The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.
van Rijn PA; Maris-Veldhuis MA; van Gennip RGP
Viruses; 2021 May; 13(5):. PubMed ID: 34067226
[TBL] [Abstract][Full Text] [Related]
4. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
5. Development of a competitive ELISA for NS3 antibodies as DIVA test accompanying the novel Disabled Infectious Single Animal (DISA) vaccine for Bluetongue.
Tacken MGJ; Daus FJ; Feenstra F; van Gennip RGP; van Rijn PA
Vaccine; 2015 Oct; 33(42):5539-5545. PubMed ID: 26387435
[TBL] [Abstract][Full Text] [Related]
6. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
Feenstra F; van Gennip RGP; Maris-Veldhuis M; Verheij E; van Rijn PA
J Gen Virol; 2014 Sep; 95(Pt 9):2019-2029. PubMed ID: 24914064
[TBL] [Abstract][Full Text] [Related]
7. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
8. Pentavalent Disabled Infectious Single Animal (DISA)/DIVA Vaccine Provides Protection in Sheep and Cattle against Different Serotypes of Bluetongue Virus.
van Rijn PA; Maris-Veldhuis MA; Spedicato M; Savini G; van Gennip RGP
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696258
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
10. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
11. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
Mokoena NB; Moetlhoa B; Rutkowska DA; Mamputha S; Dibakwane VS; Tsekoa TL; O'Kennedy MM
Vaccine; 2019 Sep; 37(41):6068-6075. PubMed ID: 31471154
[TBL] [Abstract][Full Text] [Related]
12. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
13. Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.
Feenstra F; van Rijn PA
Crit Rev Microbiol; 2017 Mar; 43(2):142-155. PubMed ID: 27800699
[TBL] [Abstract][Full Text] [Related]
14. Bluetongue virus vaccine: conventional to modern approach.
Ranjan K; Prasad M; Brar B; Lambe U; Kumar R; Ghosh M; Prasad G
Acta Virol; 2019; 63(1):3-18. PubMed ID: 30879308
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
[TBL] [Abstract][Full Text] [Related]
16. Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis.
Feenstra F; Drolet BS; Boonstra J; van Rijn PA
Parasit Vectors; 2015 Sep; 8():476. PubMed ID: 26383094
[TBL] [Abstract][Full Text] [Related]
17. Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8.
van Gennip RG; van de Water SG; Maris-Veldhuis M; van Rijn PA
PLoS One; 2012; 7(9):e44619. PubMed ID: 23049753
[TBL] [Abstract][Full Text] [Related]
18. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
[TBL] [Abstract][Full Text] [Related]
19. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
[TBL] [Abstract][Full Text] [Related]
20. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
